JPMA Drafting New Rules that Would Restrict Grants and Endowments by Drug Makers to Research Not Involving Their Own Products

Osamu Inagaki, chairman of the Japan Pharmaceutical Manufacturers Association’s (JPMA) Drug Evaluation Committee, reported on progress in the committee’s discussions on the JPMA’s rules regarding support for clinical research at a meeting of the Council for the Activation of Clinical...read more